Nov 22, 2013

Anti-Cancer Agent “Avastin^®,”
Obtained Approval for Additional Indication of Ovarian Cancer

Home
About Chugai
News
Anti-Cancer Agent “Avastin®,” Obtained Approval for Additional Indication of Ovarian Cancer

You are now moving to an external website.